Trexbio

Developer of therapeutics for immunology and cancer

placeSan Francisco, California, United States calendar_todayFounded 2019 groups65 employees language trex.bio

Social engagement

Social engagement: 12.6K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

16 investors on record; lead investors include Polaris Partners, SV Health Investors, Laurion Capital, Delos Capital Partners.

Investor typeCountShare
Venture capital744%
Private equity16%
Other / undisclosed850%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

24 Sep 2025 · Clinical Trial Manager · South San Francisco

Based on job postings tracked across public sources.

Recent activity

23 Mar 2026
Event
8th Annual Treg-Directed Therapies Summit
14 Oct 2025
Leadership hire
Board of Directors
6 Oct 2025
Recognition
Coming soon